ReviewBritish journal of clinical pharmacology2025

The new big is small: Leveraging knowledge from small trials for rare disease drug development: Blarcamesine for Rett syndrome.

Ene I Ette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.